Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia

Citation
Ymd. Lo et al., Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia, CLIN CHEM, 45(2), 1999, pp. 184-188
Citations number
28
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CLINICAL CHEMISTRY
ISSN journal
00099147 → ACNP
Volume
45
Issue
2
Year of publication
1999
Pages
184 - 188
Database
ISI
SICI code
0009-9147(199902)45:2<184:QAOFDI>2.0.ZU;2-E
Abstract
Background: There is much recent interest in the biologic and diagnostic im plication of cell-free non-host DNA in the plasma and serum of human subjec ts. To determine if quantitative abnormalities of circulating non-host DNA may be associated with certain pathologic processes, we used circulating fe tal DNA in preeclampsia as a model system. Methods: We studied 20 preeclamptic women and 20 control subjects of compar able gestational age (means, 32 and 33 weeks, respectively). Male fetal DNA in maternal serum was measured using real-time quantitative PCR for the SR Y gene on the Y chromosome. Results: The imprecision (CV) of the assay was 2.7%. The median circulating fetal DNA was increased fivefold in 20 preeclamptic women compared with 20 control pregnant women (381 vs 76 genome-equivalents/mL, P <0.001). Conclusions: These observations suggest that preeclampsia is associated wit h disturbances in the liberation and/or clearance mechanisms of circulating DNA. These results also raise the possibility that measurement of circulat ing DNA may prove useful as a marker for the diagnosis and/or monitoring of preeclampsia.